Retinopathy of prematurity screening and risk mitigation during the COVID-19 pandemic

Iason S Mantagos1, Carolyn Wu1, Joseph F Griffith1

  • 1Boston Children's Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts.

Insights

During the COVID-19 pandemic, eye care for infants with retinopathy of prematurity (ROP) was safely provided. Protocols minimized exposure risks for premature infants and ophthalmology staff, ensuring continuity of care.

Area of Science:

  • Ophthalmology
  • Neonatal care
  • Infectious disease control

Background:

  • The COVID-19 pandemic disrupted healthcare, including ophthalmology services.
  • Premature infants with retinopathy of prematurity (ROP) require ongoing, in-person eye examinations.
  • Maintaining essential care for ROP infants during the pandemic surge was critical.

Purpose of the Study:

  • To detail safety protocols for eye care providers and infants during the COVID-19 pandemic.
  • To compare ROP examination rates and outcomes from 2020 to 2019.
  • To assess the effectiveness of SARS-CoV-2 exposure mitigation strategies.

Main Methods:

  • Implementation of enhanced infection control measures in neonatal intensive care units (NICUs).
  • Increased use of personal protective equipment (PPE) for eye care staff.
  • Limitation of the number of ophthalmologists providing care in NICUs.

Main Results:

  • Despite increased ROP examination needs in 2020, fewer examinations were conducted compared to 2019.
  • No instances of missed severe ROP progression were recorded.
  • No SARS-CoV-2 transmissions occurred between ROP patients and ophthalmology personnel.

Conclusions:

  • Essential retinopathy of prematurity care was successfully delivered during the COVID-19 pandemic.
  • Implemented safety measures effectively minimized SARS-CoV-2 exposure risks.
  • Continuity of care for vulnerable infants was maintained without compromising safety.
Abstract